Direxion Daily S&P Biotech Bull 3X ETF
LABU
13 hedge funds and large institutions have $24.6M invested in Direxion Daily S&P Biotech Bull 3X ETF in 2018 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 5 increasing their positions, 6 reducing their positions, and 8 closing their positions.
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0.01% less ownership
Funds ownership: 0.35% → 0.34% (-0.01%)
17% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 6
17% less capital invested
Capital invested by funds: $29.8M → $24.6M (-$5.16M)
32% less funds holding
Funds holding: 19 → 13 (-6)
53% less call options, than puts
Call options by funds: $28.1M | Put options by funds: $59.4M
75% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 8
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
+$5.99M |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$3.4M |
| 3 |
HJMC
Hellman Jordan Management Company
Quincy,
Massachusetts
|
+$3.26M |
| 4 |
Citigroup
New York
|
+$195K |
| 5 |
Bank of Montreal
Toronto,
Ontario, Canada
|
+$112K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
-$3.6M |
| 2 |
BG
Bellevue Group
Kuesnacht,
Switzerland
|
-$2.99M |
| 3 |
Jane Street
New York
|
-$2.82M |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$2.66M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$2.62M |
LABU Hedge Fund Activity: Q1 2018 in Review
13 of the 4,373 institutional investors tracked by Wall St. Rank reported a position in Direxion Daily S&P Biotech Bull 3X ETF (LABU) for Q1 2018, worth a combined $24.6M — down 17% from $29.8M a quarter earlier.
Sellers outnumbered buyers: 8 funds closed out of LABU and 2 opened new positions — a net loss of 6 holders — while 6 trimmed existing stakes and 5 added.
The largest buyer was Wolverine Asset Management, adding an estimated $5.99M. The largest seller was Virtu Financial, cutting an estimated $3.6M.
- 13 institutional investors held Direxion Daily S&P Biotech Bull 3X ETF (LABU) as of Q1 2018, down from 19 in Q4 2017.
- Funds reported $24.6M of Direxion Daily S&P Biotech Bull 3X ETF stock for Q1 2018, down 17% quarter-over-quarter.
- 2 funds opened new Direxion Daily S&P Biotech Bull 3X ETF positions in Q1 2018 and 8 closed out, a net change of -6 holders.
- The largest Direxion Daily S&P Biotech Bull 3X ETF buyer in Q1 2018 was Wolverine Asset Management, an estimated $5.99M added.
- The largest Direxion Daily S&P Biotech Bull 3X ETF seller in Q1 2018 was Virtu Financial, an estimated $3.6M sold.
Based on aggregated 13F filings for Q1 2018.